Lord, Abbett & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-73,020
Closed -$6.03M 595
2022
Q3
$6.03M Sell
73,020
-1,300,714
-95% -$107M 0.02% 457
2022
Q2
$131M Buy
1,373,734
+60,686
+5% +$5.77M 0.46% 47
2022
Q1
$155M Buy
1,313,048
+419,157
+47% +$49.3M 0.41% 58
2021
Q4
$116M Sell
893,891
-684,749
-43% -$88.7M 0.26% 115
2021
Q3
$179M Buy
1,578,640
+996,051
+171% +$113M 0.43% 50
2021
Q2
$60.3M Buy
+582,589
New +$60.3M 0.15% 218
2020
Q1
Sell
-267,693
Closed -$20.8M 655
2019
Q4
$20.8M Sell
267,693
-235,107
-47% -$18.3M 0.07% 380
2019
Q3
$36.9M Buy
502,800
+445,557
+778% +$32.7M 0.13% 278
2019
Q2
$3.53M Sell
57,243
-470,448
-89% -$29M 0.01% 678
2019
Q1
$33.7M Sell
527,691
-291,579
-36% -$18.6M 0.11% 294
2018
Q4
$41.8M Buy
819,270
+512,706
+167% +$26.2M 0.15% 211
2018
Q3
$17.8M Sell
306,564
-489,117
-61% -$28.4M 0.05% 502
2018
Q2
$38.6M Buy
795,681
+456,486
+135% +$22.2M 0.11% 290
2018
Q1
$15.8M Buy
339,195
+83,001
+32% +$3.86M 0.05% 522
2017
Q4
$9.63M Buy
256,194
+38,772
+18% +$1.46M 0.03% 625
2017
Q3
$7.92M Sell
217,422
-33,732
-13% -$1.23M 0.02% 674
2017
Q2
$9.9M Buy
251,154
+92,625
+58% +$3.65M 0.03% 633
2017
Q1
$4.97M Sell
158,529
-70,893
-31% -$2.22M 0.01% 745
2016
Q4
$7.17M Sell
229,422
-1,492,329
-87% -$46.6M 0.02% 656
2016
Q3
$69.2M Buy
1,721,751
+226,146
+15% +$9.09M 0.21% 141
2016
Q2
$49.7M Sell
1,495,605
-713,817
-32% -$23.7M 0.16% 204
2016
Q1
$65M Buy
2,209,422
+253,329
+13% +$7.45M 0.2% 149
2015
Q4
$51.5M Buy
1,956,093
+171,009
+10% +$4.5M 0.15% 192
2015
Q3
$42.3M Buy
1,785,084
+296,550
+20% +$7.03M 0.13% 254
2015
Q2
$35.3M Buy
1,488,534
+28,782
+2% +$683K 0.09% 345
2015
Q1
$34.7M Buy
1,459,752
+916,356
+169% +$21.8M 0.09% 353
2014
Q4
$11.5M Sell
543,396
-272,148
-33% -$5.78M 0.03% 584
2014
Q3
$13.9M Buy
+815,544
New +$13.9M 0.03% 553